Our Expert in Mexico
No results available
Every company that raises capital in Mexico faces the same threshold question: should we pursue a registered public offering, or take the private placement, CKD/CBFI or securitisation route, and at what point do we need a capital markets lawyer in Mexico at the table? The answer depends on the vehicle you choose, the investors you target, the disclosure burden you can absorb and the tax treatment you need. With the Comisión Nacional Bancaria y de Valores (CNBV) tightening ESG disclosure expectations and adjusting review processes in 2025–2026, the decision point for engaging specialist counsel has shifted earlier in the deal timeline.
A capital markets lawyer is the practitioner who structures, documents and shepherds securities offerings through regulatory approval, and getting the wrong one, or getting the right one too late, can cost months and millions of pesos.
A registered public offering, whether an initial public offering (IPO) of equity or a registered debt programme, is the most visible way to raise capital in Mexico. It involves filing a prospectus with the CNBV, listing on the Bolsa Mexicana de Valores (BMV) or the Bolsa Institucional de Valores (BIVA), and meeting continuous disclosure and corporate governance requirements set out in the Ley del Mercado de Valores (Securities Market Law, or LMV). The issuer must appoint a lead underwriter (intermediario colocador), prepare audited financial statements and submit to ongoing public reporting.
Choose the public route when you need to access a broad, diversified investor base, including retail investors, and you want secondary-market liquidity for your securities. A public offering is also the path when your corporate strategy requires the credibility signal of a stock exchange listing, or when you plan to use listed equity as acquisition currency. If you intend to offer securities to the general public in Mexico, the LMV requires CNBV registration; there is no optional bypass.
Public offerings suit established issuers with mature corporate governance, audited financials that meet CNBV standards, and the budget for ongoing disclosure and compliance. Companies with annual revenues in the hundreds of millions of pesos and above, or those backed by sponsors willing to fund the listing process, are the typical candidates. Smaller issuers rarely justify the fixed costs unless they are using the BMV’s simplified listing segments designed for growth companies.
The full IPO timeline from engagement of counsel to first trade typically runs six to twelve months, though complex transactions can take longer. The preparatory phase, corporate restructuring, audit adjustments, prospectus drafting and internal approvals, usually requires three to six months before the prospectus is even filed with the CNBV. The CNBV review period itself adds additional weeks or months depending on the complexity of the filing and the volume of comments. Issuers should confirm current CNBV review timelines directly with counsel, as processing times shifted during 2025–2026.
Not every capital raise belongs on a stock exchange. Mexico’s securities framework provides several alternatives to a fully registered public offering, each with distinct mechanics, investor restrictions and regulatory treatment. Private placements, exempt offerings, Certificados de Capital de Desarrollo (CKDs), Certificados Bursátiles Fiduciarios Inmobiliarios (CBFIs), debt issuances and securitisation structures collectively represent the “private route,” though several of these instruments do trade on the BMV or BIVA under specific listing regimes.
A private placement in Mexico is typically structured as an offering exempt from the full CNBV prospectus requirements, directed at qualified or institutional investors (inversionistas calificados or institucionales) as defined in the LMV and CNBV regulations. The issuer avoids the public prospectus process but must still comply with applicable securities law restrictions, including investor eligibility verification, offering memorandum preparation and appropriate legends. The disclosure burden is negotiated between issuer and investors rather than prescribed by the regulator, preserving confidentiality and enabling faster execution.
CKDs are trust certificates designed for private equity, infrastructure and venture-style investments. They are listed on the BMV but sold exclusively to institutional and qualified investors, primarily Mexican pension funds (Afores), insurers and development banks. CBFIs serve a similar function for real estate investment, functioning as Mexico’s equivalent of a REIT vehicle. Both CKDs and CBFIs are structured through a Mexican trust (fideicomiso) and require a trustee, a manager or administrator, and a technical committee. When to use a CKD vs a bond depends on whether you need equity-like risk-sharing with institutional investors (CKD) or fixed-income debt with predetermined coupon payments (bond).
Industry observers expect CKD and CBFI issuance volumes to continue growing in 2026, driven by infrastructure spending and nearshoring-related real estate demand.
Securitisation in Mexico, typically through certificados bursátiles fiduciarios, allows issuers to package cash-flow-generating assets (receivables, tolls, mortgage pools) into trust-issued securities. Debt issuances through commercial paper (papel comercial) or medium-term notes (certificados bursátiles) can be structured as public or private depending on the target investor base. The private debt route offers speed and flexibility: issuers can negotiate covenants, amortisation schedules and prepayment terms directly with a small group of institutional buyers. The trade-off is a narrower investor base and limited secondary-market liquidity.
The following table is the centrepiece of the securities offering decision in Mexico. Use it to identify which dimensions matter most for your transaction, then read the detailed analysis below.
| Dimension | Public Offering (IPO / Registered) | Private Placement / CKD / CBFI / Bond / Securitisation |
|---|---|---|
| Typical use case | Raise capital from the broad public; achieve secondary-market liquidity and public profile | Targeted capital from institutional or accredited investors; project finance; real estate or infrastructure investment; securitisation of receivables |
| Regulatory filing | Full prospectus and registration with CNBV and BMV/BIVA; ongoing public reporting under the LMV | Often exempt from full CNBV prospectus; limited filings or registry notices depending on exemption; CKDs/CBFIs follow specific BMV listing rules |
| Disclosure burden | High, audited financials, quarterly reports, continuous event disclosure, ESG disclosures (increasing in 2026) | Lower, negotiated disclosure in offering memorandum; confidentiality preserved; CKDs/CBFIs require periodic trustee reports |
| Tax implications | ISR withholding on dividends and interest per Ley del ISR; structure-dependent VAT and transfer tax considerations; verify with tax counsel | CKDs and CBFIs can offer preferential tax treatment for institutional investors such as Afores; private debt interest withholding rates vary by investor residency; verify with tax counsel |
| Timing (typical) | 6–12+ months from engagement to closing, including CNBV review | Weeks to a few months for private placements; 3–6 months for CKD/CBFI trust formation and BMV listing |
| Costs (legal + listing) | Higher: underwriting fees, BMV listing and maintenance fees, extensive legal drafting and due diligence | Lower up-front legal fees for simple placements, but structuring costs can be significant for CKD/CBFI/securitisation vehicles |
| Liability and enforcement | Higher public liability exposure; CNBV enforcement risk; director and officer liability for prospectus misstatements | Primarily contractual liability; investor-negotiated representations and indemnities; regulatory risk present but narrower |
| Reversibility | Harder to reverse, delisting is costly, time-consuming and reputationally sensitive | More flexible, private agreements can be restructured; conversion to public offering possible if the issuer later meets listing requirements |
| Best for | Large issuers seeking liquidity, brand visibility and a broad investor base | Sponsors and issuers needing speed, confidentiality, bespoke covenants, project finance or institutional capital |
The quickest decision triggers are these: if you need to sell securities to the general public, you must register with the CNBV, there is no alternative. If your investors are exclusively institutional or qualified, the private route is almost always faster, cheaper and more confidential. If you are structuring infrastructure, real estate or private equity exposure for Afores, the CKD or CBFI vehicle is the standard market choice. The rest of the analysis below unpacks the pros and cons of a public vs private offering across each dimension.
Tax treatment is frequently the dimension that tips the securities offering decision in Mexico. Under the Ley del Impuesto sobre la Renta (ISR), dividends paid by Mexican companies are subject to a corporate-level tax and potential additional withholding depending on the distributing entity’s tax attributes. Interest payments on publicly traded debt instruments benefit from specific withholding regimes, while private debt withholding rates can vary based on the investor’s tax residency and whether the instrument qualifies under applicable tax treaty provisions.
| Tax / Cost Item | Public Offering | Private Placement / CKD / CBFI / Securitisation |
|---|---|---|
| ISR on dividends | Corporate-level ISR plus potential additional withholding on distribution; rates set by Ley del ISR | CKDs/CBFIs structured as trusts may pass through income to investors under specific trust tax rules; Afore investors benefit from preferential treatment |
| Interest withholding | Withholding on interest from listed debt per ISR provisions; reduced rates may apply to registered instruments | Private debt withholding depends on investor residency and treaty access; verify rates with tax counsel |
| Tax incentives (infrastructure / green) | Limited direct incentives for listed equity; green bond labels do not currently alter ISR treatment | CKDs used for infrastructure may access deductions and depreciation benefits at trust level; ESG labelling is market-driven, not tax-driven |
What to ask your lawyer: request a tax memo comparing the effective tax cost to both the issuer and target investor classes under each vehicle before committing to a structure.
The cost of a capital markets lawyer in Mexico varies by transaction complexity and vehicle type. For a public offering, expect counsel to deliver due diligence reports, prospectus drafting, CNBV comment responses, underwriting agreements, corporate resolutions and ongoing compliance advice. For a private placement or CKD/CBFI, the deliverable set shifts toward offering memoranda, placement agreements, trust agreements (contrato de fideicomiso), technical committee rules and tax structuring memoranda. Fee models in the Mexican market include hourly rates with a negotiated cap, flat fees for defined deliverables (such as prospectus drafting) and success-based components tied to closing. Issuers should request detailed fee proposals specifying the scope of each deliverable to avoid scope creep.
Engaging counsel at the wrong stage is the single most expensive timing mistake in Mexican capital markets transactions. For a public offering, counsel should be retained at the feasibility assessment stage, before the audit engagement is finalised and before the underwriter mandate is signed, because the corporate restructuring and governance adjustments required for CNBV compliance often take longer than anticipated. For a private placement or CKD, the engagement point is the term sheet or commitment letter stage: counsel must review investor eligibility, draft the offering memorandum and structure the trust before any binding commitment is made. Delaying counsel engagement past these milestones routinely adds two to four months to the overall timeline.
Public issuers in Mexico face regulatory enforcement by the CNBV, including administrative sanctions for prospectus misstatements, late disclosure and corporate governance failures. Directors and officers bear personal liability for material misstatements under the LMV, and underwriters face reputational and contractual exposure. In contrast, private placements primarily generate contractual liability: investors rely on negotiated representations, warranties and indemnities in the offering memorandum and subscription agreements. CKD and CBFI structures add fiduciary obligations for the trustee and the manager/administrator. Counsel should advise on directors’ and officers’ insurance coverage and negotiate appropriate indemnification language regardless of the route chosen.
Disputes arising from public offerings typically involve CNBV administrative proceedings, stock exchange disciplinary processes or civil claims in Mexican courts. Private placement disputes are usually resolved through the contractual dispute resolution mechanism, most commonly arbitration under ICC, ICDR or local arbitral institution rules, or Mexican commercial courts. A well-drafted dispute resolution clause is critical in private placements because the parties can select governing law, seat and language, flexibility that is largely unavailable in the public offering context. Counsel should draft these clauses at the documentation stage, not as an afterthought at closing.
ESG disclosure has moved from a voluntary best practice to a de facto market requirement for many Mexican capital markets transactions. The BMV’s sustainability reporting framework and the growing adoption of CNBV-aligned ESG disclosure standards mean that issuers of public securities, and increasingly issuers of CKDs and CBFIs used for infrastructure and real estate, are expected to provide verifiable environmental, social and governance data. For green bonds and sustainability-linked instruments, market practice now requires a second-party opinion or independent certification of the use-of-proceeds framework before pricing. Early indications suggest that institutional investors, particularly Afores, are incorporating ESG criteria into their investment mandates, making ESG readiness a competitive differentiator for issuers accessing Mexican institutional capital in 2026.
Counsel should be engaged before the structure is finalised to design disclosures that meet both regulatory expectations and investor due diligence requirements.
Three developments in 2025–2026 materially affect the decision calculus for anyone evaluating when to hire a capital markets lawyer in Mexico:
Each of these developments pushes the optimal counsel engagement point earlier in the transaction lifecycle. Issuers who wait until the documentation stage to retain a capital markets lawyer risk missing regulatory windows, incurring re-work costs and losing competitive positioning with institutional investors.
| If your priority is… | Choose |
|---|---|
| Maximise liquidity and public profile; you can absorb longer lead times and higher disclosure costs | Public offering (IPO / registered) |
| Speed, confidentiality, project finance, investor control or bespoke covenants | Private placement / CKD / CBFI / securitisation |
| Favourable tax structures for infrastructure exposure targeting Afores and institutional investors | CKD or CBFI with counsel-led tax structuring |
| ESG labelling for green or social debt instruments | Engage counsel early (pre-structure) to design verifiable disclosures and obtain certification |
| Securitise receivables or asset-backed cash flows | Securitisation trust (certificados bursátiles fiduciarios), private or registered depending on investor base |
Choose a public offering when:
Choose a private placement, CKD, CBFI or securitisation when:
Knowing when to hire a capital markets lawyer in Mexico is as important as choosing the right vehicle. The engagement should be staged, not left to the documentation phase:
Engage counsel immediately, at the pre-feasibility stage, if any of the following apply:
For any of these situations, you can find a capital markets lawyer through the Global Law Experts directory.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Jonatan Graham Canedo at Graham Abogados S.C., a member of the Global Law Experts network.
posted 14 minutes ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
posted 4 hours ago
posted 4 hours ago
posted 4 hours ago
posted 6 hours ago
posted 10 hours ago
posted 10 hours ago
No results available
Find the right Legal Expert for your business
Sign up for the latest legal briefings and news within Global Law Experts’ community, as well as a whole host of features, editorial and conference updates direct to your email inbox.
Naturally you can unsubscribe at any time.
Global Law Experts is dedicated to providing exceptional legal services to clients around the world. With a vast network of highly skilled and experienced lawyers, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
Global Law Experts is dedicated to providing exceptional legal services to clients around the world. With a vast network of highly skilled and experienced lawyers, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
Send welcome message